N.D. Senate committee hears proposals to lower prescription drug costs
Brayden Zenker
BISMARCK The Senate Human Services Committee heard testimony on three bills aimed at getting North Dakota consumers access to lower prescription prices.
“Most of us have never heard a good explanation of why the same drug a few miles across the border [in Canada] sells for 40%, 30% or sometimes even 20% of the price we pay in this country,” said Sen. Howard Anderson Jr., R-Turtle Lake (District 8), who introduced all three.
The first of the three, SB 2170, would create a system to set payment rates for prescription drugs based on international prices, specifically the price of those drugs in Canada. The bill would compare prescription drug prices in America to prices in Alberta, British Columbia, Ontario and Quebec. After comparison, the lowest price would be used as reference rate, or maximum rate, for consumers.
North Dakota Senate committee hears proposals to lower prescription drug costs
The Senate Human Services Committee heard testimony last week on three bills aimed at getting North Dakota consumers access to lower prescription prices.
Written By:
Brayden Zenker / N.D. Newspaper Association Education Foundation | 7:30 am, Feb. 1, 2021 ×
Steve Buissinne / Pixabay
BISMARCK The Senate Human Services Committee heard testimony last week on three bills aimed at getting North Dakota consumers access to lower prescription prices.
“Most of us have never heard a good explanation of why the same drug a few miles across the border (in Canada) sells for 40%, 30% or sometimes even 20% of the price we pay in this country,” said Sen. Howard Anderson Jr., R-Turtle Lake, who introduced all three.
Serialization 101
Fraud is a serious issue for drug manufacturing, and pharmaceutical and medical device regulations using serialization have been mandated to defend against counterfeiting.
Jan 13th, 2021
In the realm of pharmaceuticals, there are some concerning statistics according to the Pharmaceutical Research and Manufacturers of America. One in ten medicines worldwide are presumed to be counterfeit, and 95% of internet drug outlets have been found to be out of compliance with federal and state pharmacy laws & practice standards. During one week alone in March of 2020, over 48,000 packages containing counterfeit medicines were seized by Interpol.
Serialization assigns a unique serial number linked to information about the product origin, batch number, and expiration date, to each saleable unit of each prescription drug product. According to a new report by PMMI Business Intelligence, “
6 Things We Need From FDA Before Full 2023 DSCSA Enforcement
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC
The journey to industry compliance with the U.S. Drug Supply Chain Security Act (DSCSA) continues to twist and turn with recent requirements going into effect for distributors and dispenser and subsequent delays on enforcement of some of those requirements until Nov. 27, 2023. While the FDA did well to respond to requests for delays in enforcement, the postponement does not remove the active requirements of the law, and stakeholders should continue to work towards ensuring compliance and documenting their efforts in the event of potential FDA inquires or investigations. It is important to continue working on these systems and communicating with trading partners to mitigate risk and take advantage of the opportunity to stabilize systems, processes, and data.
Ohio Department of Veterans Affairs to Utilize rfxcel s Drug Supply Chain Security Act Compliance Software - US Politics Today einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.